H.P. Acthar Gel: Ph IV started

Mallinckrodt began a U.S. Phase IV trial of H.P. Acthar Gel in about 230 patients. Patients will receive 1 mL H.P Acthar Gel twice weekly for 12 weeks in an open-label part, after which patients who a...